HomeINOmax Delivery SystemsDevice Innovation

Devoted to Delivering Ongoing Innovations in Critical Care

INOmax Total Care® has been dedicated to providing state-of-the-art innovations to help mitigate the risk of device-related rebound pulmonary hypertension for over 19 years.1

The INOmax DSIR® Plus Delivery Systems are designed to deliver the most up-to-date safety features and alarms to help keep patient safety a top priority and support the ever-changing needs of the critical care space2,3:
  • Specialized, redundant, and customizable alarm features designed to help mitigate the risk of device-related rebound pulmonary hypertension2,3
  • Advanced features of the INOmax DSIR® Plus MRI enable delivery of therapy specifically for the MRI suite3
  • Integration with neonatal transport systems to help support seamless delivery of therapy2,3
  • Supports National Patient Safety Goal NPSG.06.01.01 on clinical alarm safety for hospitals and critical access hospitals4

A Legacy of Device Innovation

2000

INOvent®*

The first commercially available iNO delivery system.

2000

2006

2006

INOmax DS®*

Next-generation delivery system featuring user-friendly interface and 2 backup delivery options.

2011

INOmax DSIR®

State-of-the-art infrared technology designed to improve overall usability.

2011

2014

2014

INOmax DSIR® Plus

Enhanced software and interface with on-screen pre-use checkout and auto purge wizards, calibrations, and cell failure notifications, allowing for quick patient information.

2015

INOmax DSIR® Plus MRI

State-of-the-art infrared technology designed to improve overall usability within the MRI suite.

2015

Transport System

Available since 2000 and designed to help provide seamless delivery of INOMAX therapy during air or ground transport.

Future Delivery System Concept

Dedicated to perpetually exploring new and enhanced ways to deliver the technology you need. Future concepts focused on further enhancing patient safety and providing a more intuitive user experience are already being explored.

*No longer in use for commercial application.
The information and materials contained herein may relate to a medical device and software currently in development for which safety and efficacy have not yet been established by the FDA.